Mark Pacala Biography and Net Worth

Director of Oncology Institute

Mark Pacala brings more than 30 years of general management and private equity experience in healthcare and consumer services companies. He is a senior advisor for several private equity firms and serves on the board of several portfolio companies in the healthcare industry. Earlier in his career, he held leadership roles at Marriott Corporation and Walt Disney Company. Mr. Pacala was also CEO of Forum Group and American Whole Health. He was a general partner at Essex Woodlands Health Venture until 2009 and senior advisor at Oak Hill Capital Partners until 2016, focusing on healthcare investments. Mr. Pacala holds a Bachelor of Arts from Hamilton College and a Master of Business Administration from Harvard Business School.

What is Mark L. Pacala's net worth?: The estimated net worth of Mark L. Pacala is at least $675.39 thousand as of November 18th, 2025. Mr. Pacala owns 174,971 shares of Oncology Institute stock worth more than $675,388 as of April 30th. This net worth estimate does not reflect any other assets that Mr. Pacala may own. Learn More about Mark L. Pacala's net worth.
How do I contact Mark L. Pacala?: The corporate mailing address for Mr. Pacala and other Oncology Institute executives is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. Oncology Institute can also be reached via phone at 562-735-3226 and via email at [email protected]. Learn More on Mark L. Pacala's contact information.
Has Mark L. Pacala been buying or selling shares of Oncology Institute?: Mark L. Pacala has not been actively trading shares of Oncology Institute within the last three months. Most recently, Mark L. Pacala sold 50,000 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $4.00, for a transaction totalling $200,000.00. Following the completion of the sale, the director now directly owns 174,971 shares of the company's stock, valued at $699,884. Learn More on Mark L. Pacala's trading history.
Who are Oncology Institute's active insiders?: Oncology Institute's insider roster includes Robert Carter (CFO), Jorey Chernett (Major Shareholder), Brad Hively (Director), Mohit Kaushal (Director), Mark Pacala (Director), Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.
Are insiders buying or selling shares of Oncology Institute?: In the last year, Oncology Institute insiders bought shares 6 times. They purchased a total of 568,985 shares worth more than $1,759,600.65. In the last year, insiders at the sold shares 12 times. They sold a total of 11,585,436 shares worth more than $34,668,174.42. The most recent insider tranaction occured on April, 16th when Director Mohit Kaushal sold 38,433 shares worth more than $134,515.50. Insiders at Oncology Institute own 8.5% of the company. Learn More about insider trades at Oncology Institute.
Information on this page was last updated on 4/16/2026.

Mark L. Pacala Insider Trading History at Oncology Institute

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/18/2025	Sell	50,000	$4.00	$200,000.00	174,971
3/26/2025	Buy	90,562	$1.04	$94,184.48	224,971

Mark L. Pacala Buying and Selling Activity at Oncology Institute

Oncology Institute Company Overview

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Today's Range

Now: $3.86

$3.66

$3.91

50 Day Range

MA: $3.10

$2.55

$3.71

2 Week Range

Now: $3.86

$2.02

$4.88

Volume

1,521,954 shs

Average Volume

1,898,429 shs

Market Capitalization

$381.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.17